Does chronic oral anticoagulation with warfarin affect durability of endovascular aortic aneurysm exclusion in a midterm follow-up?
Biebl, Matthias
Does chronic oral anticoagulation with warfarin affect durability of endovascular aortic aneurysm exclusion in a midterm follow-up? [electronic resource] - Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists Feb 2005 - 58-65 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
1526-6028
10.1583/04-1337R.1 doi
Administration, Oral
Aged
Aged, 80 and over
Angiography--methods
Aortic Aneurysm, Abdominal--diagnostic imaging
Blood Vessel Prosthesis Implantation--adverse effects
Case-Control Studies
Chi-Square Distribution
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Follow-Up Studies
Humans
Male
Middle Aged
Postoperative Care--methods
Postoperative Complications--prevention & control
Probability
Prosthesis Failure
Registries
Retrospective Studies
Risk Assessment
Severity of Illness Index
Survival Rate
Time Factors
Treatment Outcome
Warfarin--therapeutic use
Does chronic oral anticoagulation with warfarin affect durability of endovascular aortic aneurysm exclusion in a midterm follow-up? [electronic resource] - Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists Feb 2005 - 58-65 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
1526-6028
10.1583/04-1337R.1 doi
Administration, Oral
Aged
Aged, 80 and over
Angiography--methods
Aortic Aneurysm, Abdominal--diagnostic imaging
Blood Vessel Prosthesis Implantation--adverse effects
Case-Control Studies
Chi-Square Distribution
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Follow-Up Studies
Humans
Male
Middle Aged
Postoperative Care--methods
Postoperative Complications--prevention & control
Probability
Prosthesis Failure
Registries
Retrospective Studies
Risk Assessment
Severity of Illness Index
Survival Rate
Time Factors
Treatment Outcome
Warfarin--therapeutic use